| Schedule of Assets and Liabilities Measured at Fair Value |
The following table summarizes the valuation of the Company’s remaining assets and liabilities measured at fair value on a recurring basis at September 30, 2026: | | | | | | | | | | | | | | | | | | | | | | | | | Total | | Quoted
prices in
active
markets
(Level 1) | | Significant
other
observable
inputs
(Level 2) | | Significant
unobservable
inputs
(Level 3) | | (in thousands) | | Assets: | | | | | | | | | Deferred compensation plan investments, current and non-current | $ | 39,003 | | | $ | 39,003 | | | $ | — | | | $ | — | | | Forward foreign currency exchange contracts | 5 | | | — | | | 5 | | | — | | | Interest rate swap agreement | 440 | | | — | | | 440 | | | — | | | Foreign currency hedge | 88 | | | — | | | 88 | | | — | | | Total assets at fair value | $ | 39,536 | | | $ | 39,003 | | | $ | 533 | | | $ | — | | | Liabilities: | | | | | | | | | Deferred compensation plan investments, current and non-current | $ | 38,992 | | | $ | 38,992 | | | $ | — | | | $ | — | | | | | | | | | | | | | | | | | | | | | | | | | | | Liability for contingent consideration, current and non-current | 24,220 | | | — | | | — | | | 24,220 | | | Total liabilities at fair value | $ | 63,212 | | | $ | 38,992 | | | $ | — | | | $ | 24,220 | |
The following table summarizes the valuation of the Company’s remaining assets and liabilities measured at fair value on a recurring basis at June 30, 2026: | | | | | | | | | | | | | | | | | | | | | | | | | Total | | Quoted
prices in
active
markets
(Level 1) | | Significant
other
observable
inputs
(Level 2) | | Significant
unobservable
inputs
(Level 3) | | (in thousands) | | Assets: | | | | | | | | | Deferred compensation plan investments, current and non-current | $ | 37,642 | | | $ | 37,642 | | | $ | — | | | $ | — | | | | | | | | | | | Interest rate swap agreement | 239 | | | — | | | 239 | | | — | | | Foreign currency hedge | 11 | | | — | | | 11 | | | — | | | Total assets at fair value | $ | 37,892 | | | $ | 37,642 | | | $ | 250 | | | $ | — | | | Liabilities: | | | | | | | | | Deferred compensation plan investments, current and non-current | $ | 37,642 | | | $ | 37,642 | | | $ | — | | | $ | — | | | Forward foreign currency exchange contracts | 3 | | | — | | | 3 | | | — | | | | | | | | | | | Liability for contingent consideration, current and non-current | 28,150 | | | — | | | — | | | 28,150 | | | Total liabilities at fair value | $ | 65,795 | | | $ | 37,642 | | | $ | 3 | | | $ | 28,150 | |
|
| Schedule of Changes in Fair Value of Contingent Considerations |
The following tables summarize the fair value of the Company's contingent consideration liabilities at September 30, 2026 and September 30, 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Contingent consideration for the quarter ended | | | | September 30, 2026 | | | | Specialty Technology Solutions | | Intelisys & Solution Services | | | | Total | | | | | | | | | | (in thousands) | | Fair value at beginning of period | $ | 15,880 | | | $ | 12,270 | | | | | $ | 28,150 | | | | | | | | | | | | | | | | | | | | | | | | | | | Payments | (3,783) | | | — | | | | | (3,783) | | | | | | | | | | | | | | | | | | | | | | | | | | | Change in fair value of contingent consideration | 473 | | | (620) | | | | | (147) | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair value at end of period | $ | 12,570 | | | $ | 11,650 | | | | | $ | 24,220 | | | | | | | | | | | | | | | | | | | | | | | | | | | Contingent consideration for the quarter ended | | | | September 30, 2025 | | | | Specialty Technology Solutions | | Intelisys & Solution Services | | | | Total | | | | | | | | | | (in thousands) | | Fair value at beginning of period | $ | 6,660 | | | $ | 12,440 | | | | | $ | 19,100 | | | | | | | | | | | | | | | | | | | | | | | | | | | Payments | (1,375) | | | — | | | | | (1,375) | | | | | | | | | | | | | | | | | | | | | | | | | | | Change in fair value of contingent consideration | 145 | | | 169 | | | | | 314 | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair value at end of period | $ | 5,430 | | | $ | 12,609 | | | | | $ | 18,039 | | | | | | | | | |
Significant observable inputs used in recurring Level 3 fair value measurements for the Company's contingent consideration liabilities by segment related to acquisitions at September 30, 2026 and September 30, 2025 were as follows. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Significant observable inputs | | Significant observable inputs | | | September 30, 2026 | | September 30, 2025 | | Acquisition | | Specialty Technology Solutions | | Intelisys & Solution Services | | | | Specialty Technology Solutions | | Intelisys & Solution Services | | | | Weighted-average payor credit spread | | 1.02 | % | | 1.02 | % | | | | 1.80 | % | | 1.80 | % | | | | Weighted-average adjusted EBITDA risk premium | | 12.40 | % | | 12.70 | % | | | | 15.30 | % | | 12.70 | % | | | | Adjusted EBITDA volatility | | 60.00 | % | | 50.00 | % | | | | * | | 40.00 | % | | | | | | | | | | | | | | | | *Not applicable to the Specialty Technology Solutions segment for the quarter ended September 30, 2026. | | |
|